Valuation: PharmaEssentia Corporation

Market Cap 526B 16.05B 14.4B 13.16B 12.01B 22.63B 1,509B 23.34B 159B 63.25B 805B 60.26B 58.96B 2,542B P/E 2026 *
48.2x
P/E 2027 * 29.8x
Enterprise Value 503B 15.35B 13.77B 12.58B 11.49B 21.64B 1,443B 22.32B 152B 60.48B 770B 57.62B 56.38B 2,431B EV / Sales 2026 *
18.6x
EV / Sales 2027 * 11.9x
Free-Float
79.23%
Yield 2026 *
0.31%
Yield 2027 * 0.19%
1 day+7.17%
1 week+2.42%
Current month+6.72%
1 month+6.72%
3 months-4.87%
6 months+117.74%
Current year+199.74%
1 week 1,075
Extreme 1075
1,295
1 month 1,075
Extreme 1075
1,300
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 77.99
Extreme 77.985382
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 2016-12-31
Director of Finance/CFO - 2015-10-13
President - 2015-06-24
Director TitleAgeSince
Director/Board Member - 2000-05-08
Chairman - 2012-09-23
Director/Board Member - 2015-05-28
Change 5-day change 1-year change 3-year change Capi.($)
+7.17%+2.42%+184.32%+358.47% 14.86B
-4.83%+2.88%+55.87%+69.12% 69.4B
+0.02%+1.42%+12.77%+75.21% 57.24B
-1.34%+3.53%+23.22%+101.58% 57.62B
+2.62%+1.68%+28.91%+37.01% 43.65B
+5.09%+9.89%+22.45%+107.48% 44.03B
+8.24%+0.51%+213.26%+792.66% 38.08B
-1.86%+11.46%+26.67%+61.40% 36.31B
-2.97%-6.89%+91.79%+74.60% 32.61B
-2.18%+5.68%+36.21%-0.69% 25.47B
Average +1.01%+2.68%+69.55%+167.69% 41.93B
Weighted average by Cap. +0.32%+2.59%+57.10%+146.58%

Financials

2026 *2027 *
Net sales 27.07B 826M 741M 677M 618M 1.16B 77.62B 1.2B 8.16B 3.25B 41.42B 3.1B 3.03B 131B 41.5B 1.27B 1.14B 1.04B 947M 1.78B 119B 1.84B 12.51B 4.99B 63.49B 4.75B 4.65B 200B
Net income 10.52B 321M 288M 263M 240M 452M 30.17B 467M 3.17B 1.26B 16.1B 1.2B 1.18B 50.82B 17.96B 548M 491M 449M 410M 772M 51.5B 797M 5.41B 2.16B 27.48B 2.06B 2.01B 86.75B
Net Debt -23.05B -703M -631M -576M -526M -991M -66.08B -1.02B -6.95B -2.77B -35.26B -2.64B -2.58B -111B -34.24B -1.04B -937M -856M -781M -1.47B -98.18B -1.52B -10.32B -4.11B -52.39B -3.92B -3.84B -165B
Projected Income Statement - Annual - PharmaEssentia Corporation
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
26-11-05 NT$1,270.00 +7.17% 7,184,223
26-11-05 NT$1,185.00 -5.20% 3,513,424
26-11-04 NT$1,250.00 +2.04% 3,877,750
26-11-03 NT$1,225.00 +2.94% 2,547,881
26-11-02 NT$1,190.00 0.00% 1,121,084
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - PharmaEssentia Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,270.00TWD
Average target price
1,437.27TWD
Spread / Average Target
+13.17%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - PharmaEssentia Corporation
  1. Stock Market
  2. Stocks
  3. 6446 Stock